drugset / Trial / NCT01102673
Single Dose Study of PF-04991532 in Healthy Subjects
RandomizedCrossoverDouble-blind
Summary
The purpose of this study is to characterize the safety, tolerability, pharmacokinetics (PK) and preliminary food effect of PF-04991532 following single escalating oral doses in healthy adult subjects.
Timeline
- Start
- 2010-04
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-04991532 | Small molecule | 30 mg | Oral |
| Subject | PF-04991532 | Small molecule | 100 mg | Oral |
| Subject | PF-04991532 | Small molecule | 300 mg | Oral |
| Subject | PF-04991532 | Small molecule | 600 mg | Oral |
| Subject | PF-04991532 | Small molecule | 1200 mg | Oral |
| Subject | PF-04991532 | Small molecule | 2000 mg | Oral |